A comprehensive investigation of the incentives and policies in the Japanese generic drug market

全面考察日本仿制药市场激励政策

• 批准号: 22K13423
• 负责人: 富 蓉
• 金额: $ 2.83万
• 依托单位: Waseda University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Early-Career Scientists
• 财政年份: 2022
• 资助国家: 日本
• 起止时间: 2022-04-01 至 2026-03-31
• 项目状态: 未结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-22K13423/
• 关键词: generic drugs

The objective of this project is to investigate the incentives that prescribing physicians and dispensing pharmacies face when using generic drugs, as well as how current polices have impacted prescription and dispensing behaviors for generic drug promotion. With three types of incentives that physicians and pharmacies face—patient welfare, financial gains, and psychological costs;we aim to (1) assess if the incentives influence physicians' and pharmacies' willingness to prescribe and dispense generics, and if so, how they respond differently to the incentives. Furthermore, by focusing in-depth on generic-promotion policies, we expect to determine (2) whether the policies encouraged physicians to prescribe generics; (3) whether the policies motivated pharmacists to dispense generics.

本项目的目的是调查处方医生和配药药房在使用仿制药时面临的激励因素，以及当前政策如何影响仿制药推广的处方和配药行为。医生和药房面临三种类型的激励措施，患者福利，财务收益和心理成本;我们的目标是（1）评估激励措施是否影响医生和药房开处方和分发仿制药的意愿，如果是这样，他们如何对激励措施做出不同的反应。此外，通过深入关注仿制药推广政策，我们希望确定（2）政策是否鼓励医生开仿制药;（3）政策是否激励药剂师开仿制药。

项目成果

In Utero Exposure to Radiation Fear and Birth Outcome: Evidence from Fukushima Nuclear Power Plant Accident

子宫内辐射恐惧与出生结果：福岛核电站事故的证据

• 发表时间: 2022
• 作者: Haiyan Bai;M. H. Clark;大久保 将貴;黒川 博文;佐藤香織;Rong FU
• 通讯作者: Rong FU